Mounjaro vs. semaglutide: Which is better for weight loss?

Key Points

• Semaglutide (Ozempic, Wegovy) works by targeting one hormone (GLP-1), while tirzepatide (Mounjaro, Zepbound) targets two hormones (GLP-1 and GIP) for a dual-action effect.
• Trzepatide consistently shows a greater percentage of weight loss compared to semaglutide in studies.
• For people with type 2 diabetes, tirzepatide has also been shown to be more effective at lowering A1c (a measure of long-term blood sugar) than semaglutide.

It feels like everyone is talking about Mounjaro, Ozempic, and Wegovy, and it's easy to feel lost in the sea of brand names. It’s clear that these medications work – but you're trying to figure out the differences to see which option is best for you.

Let's cut through the confusion. While there are similarities amongst these big names, they are not all the same drug. The biggest difference comes down to how they work in your body, with one option acting on two different hormones while the other only acts on one.

Here’s a straightforward breakdown of what sets Mounjaro (tirzepatide) and semaglutide apart.

The main difference between Mounjaro & semglutide: one hormone vs. two

The core distinction between these two powerful medications comes down to how they work.

How semaglutide works (Ozempic & Wegovy)

Semaglutide is known as a GLP-1 (glucagon-like peptide-1) receptor agonist.

That sounds technical, but the idea is simple. Semaglutide, the main ingredient in Ozempic and Wegovy,  mimics a natural gut hormone called GLP-1. After you eat, your body releases GLP-1 to do a few important jobs: It signals to your brain that you’re full, slows down how quickly food leaves your stomach, and helps your pancreas release insulin to manage blood sugar.

By acting like GLP-1, semaglutide helps reduce appetite and quiet the "food noise", making it easier to feel satisfied with less food.

How Mounjaro works (tirzepatide)

Tirzepatide, the active ingredient in Mounjaro and Zepbound, takes it a step further. It’s the first-ever drug that's a dual GIP and GLP-1 receptor agonist.

This means it mimics two different gut hormones:

1. GLP-1: The same hormone that semaglutide targets
2. GIP (glucose-dependent insulinotropic polypeptide): Another key hormone that also helps release insulin and may play an additional role in how your body manages energy

By targeting both of these pathways, tirzepatide gives you a more comprehensive, dual-action approach to regulating blood sugar and appetite. 

“Semaglutide works on one pathway that tells your body to feel fuller and manage blood sugar,” says Lyla Joffe, RD. “Tirzepatide works on two pathways, so it’s like having a double team working together, which often leads to more powerful results.”

Which is better for weight loss, semaglutide or Mounjaro?

This is what most people really want to know. While both medications are proven to be effective, tirzepatide has a clear advantage over semaglutide.

The results in a landmark study were clear: participants taking tirzepatide lost significantly more weight at all dose levels compared to those on the highest dose of semaglutide.

To put that in perspective, people on the highest dose of tirzepatide (15 mg) lost about 25 pounds on average, while those on the highest dose of semaglutide (1 mg) lost about 13 pounds.

It’s important to note, however, that the highest dose for semaglutide is now 2.2 mg (versus 1 mg used in the study), so more direct comparison is needed.

More recent analyses of real-world data back this up, finding that people taking tirzepatide were much more likely to achieve weight loss milestones of 5%, 10%, and 15% compared to those on semaglutide.

“Tirzepatide shows 5-8% greater weight loss in studies than semaglutide,” says Lyla Joffe, RD, “and many patients report feeling fuller on lower dosages, too. This signals that tirzepatide is more potent and quite possibly more effective for weight loss.”

Of course, these are just averages. Your personal results will depend on everything from your starting weight and genetics to your daily food choices and activity levels.

What about blood sugar control for type 2 diabetes?

Beyond weight loss, these medications are game-changers for managing type 2 diabetes. And here again, the evidence suggests tirzepatide's dual action has a stronger impact.

One study found that tirzepatide was more effective at lowering A1c levels – the key indicator of your average blood sugar over three months – than semaglutide. A much higher percentage of people taking tirzepatide reached the target A1c of less than 7% (the goal for many with diabetes) compared to those on semaglutide.

A recent meta-analysis that reviewed multiple studies came to the same conclusion, stating that tirzepatide showed superior results for both blood sugar control and weight reduction.

Are the side effects the same between the medications?

The side effects are a major concern for most people. Because both drugs work on the digestive system, they share a very similar list of common side effects:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Stomach pain

These issues are usually most noticeable when you first start the medication or increase your dose. For many people, they get better over time as their body adjusts.

So, is one easier on the stomach than the other? The data from one trial showed the rates were fairly close. Nausea, for example, was reported by 18% to 22% of tirzepatide users (depending on the dose) compared to 18% of semaglutide users. Diarrhea was also a bit more common with tirzepatide.

Managing these side effects is key to sticking with the treatment. This is where working with a registered dietitian comes in. They can give you practical strategies, like eating smaller meals, staying hydrated, and avoiding specific trigger foods that can make symptoms worse.

Understanding approvals, brands, and cost

Keeping all the medications straight can be a headache, so here’s a simple way to keep them straight. Think of it as the ingredient name versus the brand name.

Active Ingredient: Semaglutide

• Ozempic: The brand name for the dose approved to treat type 2 diabetes
• Wegovy: The brand name for the higher dose approved for chronic weight management
• Rybelsus: The brand name for the oral tablet version of semaglutide for diabetes

Active Ingredient: Tirzepatide

• Mounjaro: The brand name for the dose approved to treat type 2 diabetes
• Zepbound: The brand name for the dose approved for chronic weight management

Which medications are covered by insurance?

Both medications are very expensive if you pay out of pocket, often costing more than $1,000 a month. Insurance coverage is the biggest hurdle for many. Plans vary significantly, and some will cover these drugs for diabetes but not for weight loss. The first step is always to check directly with your insurance provider to see what’s covered under your specific plan.

Final thoughts: Which one is right for you?

So, after all that, what’s the final verdict? The clinical evidence strongly suggests that tirzepatide (Mounjaro and Zepbound) leads to more weight loss and better blood sugar control than semaglutide (Ozempic and Wegovy).

But the "best" medication is always the one that’s right for you.

This is a decision to make with your healthcare provider, not based on a headline. They will look at your complete health picture, your specific goals, any other medical conditions you have, and the practical reality of what your insurance will cover. For some people, one drug may be more tolerable or accessible than the other.

No matter which medication you choose, it’s vital to understand that it’s a tool, not a cure. The best results always come from combining the medication with sustainable lifestyle changes, like improving your nutrition and finding ways to move your body that you enjoy.

You don't have to figure all that out alone. Partnering with a registered dietitian specializing in weight loss can give you a personalized plan and the supportive guidance you need to make those changes last.

Frequently asked questions

Is Mounjaro stronger than Ozempic?

Based on head-to-head clinical studies, Mounjaro (tirzepatide) has been shown to be more effective, or "stronger," for both weight loss and lowering blood sugar compared to Ozempic (semaglutide). This is believed to be because it targets two helpful gut hormones (GIP and GLP-1) instead of just one.

Can you switch from semaglutide to tirzepatide?

Yes, people can and do switch from a semaglutide medication to a tirzepatide one. This must be done under a doctor's supervision, as they will need to guide you on how to stop one and start the other safely, including determining the right starting dose.

What is the main difference in side effects between Mounjaro and semaglutide?

The types of side effects are almost identical, mainly digestive issues like nausea, diarrhea, and vomiting. Some clinical trials suggest these side effects might happen a little more frequently with tirzepatide, especially at higher doses, but everyone's experience is different.

Is tirzepatide a GLP-1?

Yes, tirzepatide is a GLP-1 receptor agonist, but it's also a GIP receptor agonist. This makes it a "dual-agonist." So, while it does the same job as a GLP-1 drug like semaglutide, it has an extra layer of action on the GIP pathway, which is what makes it unique.

The views expressed by authors and contributors of such content are not endorsed or approved by Fay and are intended for informational purposes only. The content is reviewed by Fay only to confirm educational value and audience interest. You are encouraged to discuss any questions that you may have about your health with a healthcare provider.